
Mpox Awareness Stays Low Among U.S. Adults
Less than half of survey respondents know a mpox vaccine exists, so check with your doctor about vaccination if you are at higher risk.
Live Poll
Do you know a mpox vaccine exists?

Less than half of survey respondents know a mpox vaccine exists, so check with your doctor about vaccination if you are at higher risk.
Live Poll
Do you know a mpox vaccine exists?
November 20, 2026
Flu Vaccines Often Protect Less Than CitedAdults who get the annual flu shot should know its protection against infection has often fallen below the commonly cited range.
November 12, 2026
CDC Ranks Drug-Resistant Germs; C. Diff EasesThe 2026 report rates four resistant pathogens as Urgent and lowers C. difficile to Serious after measured case declines.
November 3, 2026
Adult Pneumococcal Hospitalizations Rise Despite New VaccinesA preliminary IDWeek 2026 study found adults' serious pneumococcal infections rose 16% to 23% above baseline while children's stayed flat.
October 31, 2026
New Chronic Disease Tracking Platform LaunchesThe tool allows researchers to map chronic disease trends and social determinants across the U.S. from 2020 to 2025.
October 29, 2026
Post-COVID Smell Loss Trends Affect Many AdultsNew survey data shows that while most people recover their sense of smell after COVID-19, millions face long-term issues.
October 29, 2026
New Transthyretin Protein Unfolding Pathway IdentifiedThe study explains how protein variants unfold in acidic conditions, a key factor in how proteins aggregate in the body.
October 28, 2026
Standard Antibiotic Treatment Fails Many Enteric Fever CasesFor patients with enteric fever, standard antibiotics like ciprofloxacin are increasingly ineffective, necessitating new care plans.
October 27, 2026
C. diff Diagnostic Challenges Complicate Clinical CareChemotherapy and transplant patients may struggle to distinguish between asymptomatic carriage and an active infection.
October 26, 2026
New Hepatitis B Immunotherapy to Be Presented in DenverThe data offers hope for better viral control for adults living with chronic hepatitis B.
October 26, 2026
FDA Approves New Herpes Treatment for ImmunocompromisedThe new oral medication offers a potential path for healing resistant HSV lesions in high-risk patients.